Search the hub
Showing results for tags 'Medicine - Respiratory'.
Found 109 results
-
Content ArticlePaediatric cardiac arrest is unlikely to be caused by a cardiac problem and is more likely to be a respiratory one, making ventilations crucial to the child’s chances of survival. However, for those not trained in paediatric resuscitation, the most important thing is to act quickly to ensure the child gets the treatment they need in the critical situation. This page contains:an EPALS algorithm for paediatric COVID-19 patients.a flowchart on the resuscitation of paediatric COVID-19 patients in hospital.
-
Content ArticleThis blog from the European Respiratory Society, discusses a joint statement that was signed by individuals working on behalf of the Italian Thoracic Society (ITS - AIPO), Association for the Rehabilitation of Respiratory Failure (ARIR) and the Italian Respiratory Society (SIP/IRS). They conclude that the dramatic spread of the current COVID-19 epidemic in Italy has spurred into action also respiratory rehabilitation specialists (pulmonologists and respiratory therapists), who have been engaged for years in the care of patients with disabilities secondary to respiratory diseases and/or conditions. Their experience acquired in the management of chronic and acute respiratory failure is proving to be a fundamental asset for the management of patients during COVID-19 epidemic. Hence, it is likely that the reorganisation involved in taking care of this scenario will not be a short-term matter.
-
Content Article
British Thoracic Society: COVID-19 resources for people with lung disease
Claire Cox posted an article in Guidance
The British Thoracic Society have drawn together the following links to information for patients with lung disease and COVID-19. These include: asthma cystic fibrosis mesothelioma pulmonary fibrosis sarcoidosis UK travel advice for patients tuberculosis lung cancer -
Content ArticleThis document from the British Thoracic Society links to updated guidance in the treatment of COPD patients and COVID-19.
-
Content ArticleThis page, created by the British Thoracic Society, contains information, guidance and resources to support the respiratory community during the COVID-19 pandemic.
-
Content ArticleInhalers are a key treatment for respiratory conditions, with approximately 60 million dispensed in England every year. However, inhalers are not always used in an optimal way, which can lead to poor disease control and avoidable deaths. Inhaler emissions account for approximately 3% of the NHS carbon footprint. The propellant used in metered dose inhalers is responsible for most of these emissions. Alternative options with a significantly lower carbon footprint exist, such as dry powder inhalers. The UK has a higher metered dose inhalers prescribing rate compared with other European countries. These countries have demonstrated that safe and effective care can still be delivered using other inhaler devices. Wyre Forest Health Partnership (WFHP) was formed from a merger of five GP practices and now comprises of six sites across Worcestershire with over 50 doctors, 200+ staff, and more than 73,000 patients. WFHP identified that, in line with the UK, they too had high prescribing rates for metered dose inhalers, and decided to act – to improve the health of their respiratory patients, while reducing their environmental impact. This case study shows what they did.
-
Content ArticleThe overarching objective of the national Adoption and Spread Safety Improvement Programme (A&S-SIP) is to identify and support the spread and adoption of effective and safe evidence-based interventions and practice. Each of the four objectives of this programme intend to make medical procedures, and discharges from acute settings, as safe as possible whilst driving forward innovation within healthcare. Learn how the programme is being delivered locally by the West of England Patient Safety Collaborative.
-
Content Article
WHO European non-communicable disease dashboard (January 2022)
Patient-Safety-Learning posted an article in WHO
Non-communicable diseases (NCDs) including cardiovascular disease, cancer, chronic respiratory disease and diabetes, are leading causes of morbidity, disability and mortality in the WHO European Region, causing nearly 90% of all deaths and 67% of premature deaths. The World Health Organization (WHO) Regional Office for Europe has released the WHO Europe NCD Dashboard, which provides graphical data on NCDs in the 53 Member States of the Region and makes comparisons between them. The dashboard enables analysis of a country’s health situation and its progress towards meeting NCD health targets. It includes standardised data from national and international registries and surveys collected by countries, WHO and other international organisations -
Content ArticleThe Surviving Sepsis Campaign panel recently recommended that “mechanically ventilated patients with COVID-19 should be managed similarly to other patients with acute respiratory failure in the ICU.” However, COVID-19 pneumonia, despite falling in most of the circumstances under the Berlin definition of ARDS, is a specific disease, whose distinctive features are severe hypoxemia often associated with near normal respiratory system compliance. In their paper published in Intensive Care Medicine, Gattinoni et al. hypothesise that the different COVID-19 patterns found at presentation in the emergency department depend on the interaction between three factors: (1) the severity of the infection, the host response, physiological reserve and comorbidities; (2) the ventilatory responsiveness of the patient to hypoxemia; and (3) the time elapsed between the onset of the disease and the observation in the hospital.
